Our Team in the News

BioPlan Associates' Ronald Rader

Ron Rader, Sr. Dir. Technical Research: named Editor-in-Chief of Biopharmaceuticals a new peer-reviewed journal from Landes Bioscience. Biopharmaceuticals is the first and only peer-reviewed journal about biopharmaceuticals. Biopharmaceuticals seeks submission of articles concerning biopharmaceuticals and the industry. Please contact the Editor-in-Chief if interested in submitting an article.

BioPlan Associates' Faiz Kermani PhD

Dr Faiz Kermani, Advisory Board: Has helped establish the "Global Health Education Foundation" (GHEF), a not-for-profit healthcare charity to improve educational resources and training for healthcare professionals in developing countries.
At least 1.3 billion people worldwide lack access to the most basic healthcare. The new non-profit foundation, Global Health Education Foundation, aims to tackle such issues. As President of GHEF, Dr Kermani is supporting the R&D focus of the charity to reduce health disparities among developing countries. In particular, the lack of appropriate educational resources and training opportunities for healthcare professionals. http://www.globalhef.org

BioPlan Associates' Managing Director Eric Langer

Eric Langer, Managing Partner: On Advisory Board of “BioProcess Asia Pacific Conference” July 2010 Singapore.
The Biopharmaceutical market in Asia pacific is growing at a rate among the highest in the globe. This is creating a strong need for production of biopharmaceuticals at higher qualities and volumes. Bioprocess AsiaPacific brings together global leaders within biopharmaceutical industry to explore dynamic strategies, benchmark technologies and analyze sustaining the growth of the industry. http://fleminggulf.com/conference/life-science/BioProcessAsiaPacific.


New Product Development Quick Test

Estimating the probability of success is important for any product or service. In fact, do this right now for a new product you might be involved with, or for your marketing plan product:

  1. Roughly estimate the overall probability of success. Multiply:

    % Probability of technical completion
    X % Probability that it will actually be commercialized
    X % Probability that market will accept the product, and you will be profitable

    = Likelihood of a Successful New Product Launch
    Imagine a novel DNA purification system. You estimate that there is a:
    90% Likelihood that the basic concept will work, technically
    X 80% Likelihood of creating a cost-effectively produced, commercial product
    X 80% Likelihood of market acceptance/profitability

    = 58% Probability of New Product Launch Success
  1. Decide if you (or your investors) can live with that probability. Given the numbers above, there's a little more than a 50/50 chance that you'll make it as a commercial success. Do you think this will impress your investors? Your senior management? Does this impress you?
  1. Determine which part of the probability equation you must change in your favor. What will you do to increase your probability of success? Here is where you can pre-empt a failure and pull off a new product success.

No matter what the answer, it's essential to have an effective new product development model.